Simulations Plus partners with global pharma company on AI-enabled QSP modeling using Turin
Bitget2026/10/08 13:15Simulations Plus entered a funded partnership with a large global pharmaceutical company to deploy its Turin AI engine in an active drug program. Collaboration aims to cut QSP model build and evaluation timelines by scaling exploration of mechanistic model structures. Pharma partner will run Turin in a hosted environment with support from Simulations Plus scientists during model evaluation. Agreement targets broader use of QSP in model-informed drug development, with plans to expand into additional therapeutic programs. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Simulations Plus Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610080915BIZWIRE_USPR_____20261008_BW831077) on October 08, 2026, and is solely responsible for the information contained therein.
- Simulations Plus entered a funded partnership with a large global pharmaceutical company to deploy its Turin AI engine in an active drug program.
- Collaboration aims to cut QSP model build and evaluation timelines by scaling exploration of mechanistic model structures.
- Pharma partner will run Turin in a hosted environment with support from Simulations Plus scientists during model evaluation.
- Agreement targets broader use of QSP in model-informed drug development, with plans to expand into additional therapeutic programs.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny
CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.
Canadian used car dealer UC Automotive (UCAU.RC.US) files for IPO in the US: aims to raise 29 million USD and list on Nasdaq
Canadian used car dealer UC Automotive has applied for a Nasdaq IPO, aiming to raise up to $29 million, with its main focus on the Greater Vancouver market. Kingswood is the sole underwriter.
Crypto prices
More
